“The Repair Peptide”
Derived from a protein found in gastric juice, promotes new blood vessel growth toward damaged tissue, which is the basic engine behind why it's so associated with faster healing.
Research suggests BPC-157 promotes angiogenesis (new blood vessel formation) and interacts with growth-factor and nitric-oxide pathways involved in healing, the proposed basis for its effects on tendon, ligament, muscle, and gut tissue repair in animal models.
It's not FDA-approved for human use. It has been under regulatory scrutiny as part of the FDA's review of bulk compounding substances, and its legal status has been actively shifting, so check current rules before assuming anything.
There's no clinically established human timeline, since there are no large published human trials. Specific day-by-day timelines you see online are anecdotal, not clinical data.
Animal studies report a favorable short-term profile, but long-term human safety hasn't been established in published clinical trials.
The overwhelming majority of BPC-157 research consists of rodent studies, much of it from a research group led by the Croatian pharmacologist Predrag Sikirić, examining tendon-to-bone healing, gut protection, and wound recovery. There are currently no large, published, peer-reviewed human trials confirming these effects.
Everything on this page, plus the exact reconstitution math, dosing progression, cycle length, and every warning sign, in one focused guide.
A focused, start-to-finish guide built around BPC-157 specifically. No filler, no padding, just what you need.
Get The Protocol · $10